Zoran Mandić

Title: Zoran Mandić: Innovator in Pharmaceutical Chemistry

Introduction

Zoran Mandić is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on macrolide compounds. His research has led to advancements that may impact the development of new therapeutic agents.

Latest Patents

Zoran Mandić holds a patent for "Hydroxy derivatives of tylosin and process for their preparation." This invention relates to 12,13-dihydroxy derivatives of tylosin, which are new semisynthetic compounds of the macrolide class. The process involves the oxidation of a 13-hydroxy derivative to obtain a 12,13-dihydroxy compound. This compound can undergo various reactions, including oximation, reduction, or hydrolysis, yielding corresponding dihydro or tetrahydro 12,13-dihydroxy derivatives. He has 1 patent to his name.

Career Highlights

Zoran Mandić is associated with Pliva, Farmaceutska Industrija, Dionicko Drustvo, a prominent pharmaceutical company in Croatia. His work at Pliva has allowed him to engage in cutting-edge research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the company's product offerings and enhancing its research capabilities.

Collaborations

Zoran has collaborated with several professionals in his field, including Amalija Narandja and Nevenka Lopotar. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical compounds.

Conclusion

Zoran Mandić's work exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions, particularly in the area of macrolide compounds, highlight the importance of research and development in creating new therapeutic options. His achievements continue to inspire future advancements in the field.